Valuation: American Vanguard Corporation

Capitalization 75.34M 63.82M 58.72M 55.58M 103M 6.97B 105M 688M 270M 3.38B 283M 277M 11.91B P/E ratio 2024
-1.03x
P/E ratio 2025 -2.18x
Enterprise value 254M 215M 198M 188M 348M 23.53B 354M 2.32B 910M 11.41B 954M 934M 40.2B EV / Sales 2024
0.53x
EV / Sales 2025 0.56x
Free-Float
75.24%
Yield 2024
1.3%
Yield 2025 -
1 day+1.15%
1 week+13.30%
Current month+6.02%
1 month-24.57%
3 months-38.60%
6 months-49.43%
Current year-30.89%
1 week 2.3
Extreme 2.3
2.8
1 month 2.05
Extreme 2.05
3
Current year 2.05
Extreme 2.05
5.55
1 year 2.05
Extreme 2.05
5.92
3 years 2.05
Extreme 2.05
21.04
5 years 2.05
Extreme 2.05
25.99
10 years 2.05
Extreme 2.05
25.99
Manager TitleAgeSince
Chief Executive Officer 57 2024-12-08
Director of Finance/CFO 69 2008-03-06
Chief Executive Officer 66 2024-07-11
Director TitleAgeSince
Director/Board Member 72 2014-01-06
Director/Board Member 65 2019-11-30
Director/Board Member 64 2021-12-08
Change 5d. change 1-year change 3-years change Capi.($)
+1.15%+13.30%-30.53%-87.72% 75.34M
-1.01%-4.16%+34.48%+27.99% 53.94B
+0.11%-.--%-.--%-.--% 12.96B
-0.30%+4.93%+140.81%+194.55% 12.62B
-1.33%-0.30%+51.09%+61.00% 8.92B
-1.69%+1.16%-17.74%-18.25% 6.76B
+3.54%+5.26%+18.65%+170.20% 6.31B
+0.82%+3.13%+1.37%-9.78% 6.07B
+0.96%+6.50%-13.77%+3.41% 5.16B
+1.79%+2.76%+46.43%+34.91% 4.82B
Average +0.40%+2.99%+23.08%+37.63% 11.76B
Weighted average by Cap. -0.33%-0.20%+36.12%+47.43%

Financials

2024 2025
Net sales 547M 464M 427M 404M 748M 50.64B 761M 5B 1.96B 24.55B 2.05B 2.01B 86.52B 515M 436M 401M 380M 704M 47.66B 717M 4.7B 1.84B 23.11B 1.93B 1.89B 81.43B
Net income -126M -107M -98.47M -93.2M -173M -11.69B -176M -1.15B -452M -5.67B -474M -464M -19.97B -49.88M -42.26M -38.88M -36.8M -68.19M -4.62B -69.39M -455M -179M -2.24B -187M -183M -7.89B
Net Debt 155M 132M 121M 115M 212M 14.37B 216M 1.42B 556M 6.97B 583M 570M 24.55B 179M 152M 139M 132M 245M 16.56B 249M 1.63B 641M 8.03B 671M 657M 28.29B
Logo American Vanguard Corporation
American Vanguard Corporation is a diversified specialty and agricultural products company. The Company develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. The Company conducts its business through its operating subsidiaries, including AMVAC Chemical Corporation (AMVAC) for its domestic business and AMVAC Netherlands BV (AMVAC BV) for its international business. AMVAC manufactures chemical, biological and biorational products that develop and markets solutions for agricultural, commercial and consumer uses. Its products include insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals, and are marketed in liquid, powder, and granular forms. AMVAC BV sells products both directly and through its network of subsidiaries in various international territories. It also manufactures microbial cleaning products, BioMop-Plus and DrainGel.
Employees
739
Date Price Change Volume
26-04-17 2.640 $ +1.15% 293,624
26-04-16 2.610 $ +3.98% 289,378
26-04-15 2.510 $ -4.56% 291,512
26-04-14 2.630 $ +3.14% 630,548
26-04-13 2.550 $ +9.44% 339,693
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB

Quarterly revenue - Rate of surprise